Synthesis and study of benzofuran-pyran analogs as BMP-2 targeted osteogenic agents

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Osteoporosis is a debilitating bone disease characterized by low bone mass and microarchitectural deterioration.
• Developing novel anabolic agents to stimulate bone formation is crucial for effective osteoporosis treatment.

Purpose of the Study:

• To synthesize and evaluate novel benzofuran-pyran derivatives for anti-osteoporotic activity.
• To identify potent compounds that stimulate osteoblast differentiation and mineralization.

Main Methods:

• Synthesis of twenty-four novel benzofuran-pyran derivatives.
• In vitro evaluation of anti-osteoporotic activity using primary rat calvarial osteoblasts.
• Assays included alkaline phosphatase activity, alizarin red-S staining for mineralization, and molecular dynamics simulations.
• Molecular dynamics simulations were used to assess binding to the BMP-2 receptor.

Main Results:

• Compounds 4e, 4j, and 4k demonstrated potent osteoblast differentiation stimulation at picomolar concentrations.
• These compounds effectively promoted mineralization as assessed by alizarin red-S staining.
• Molecular dynamics simulations indicated that both benzofuran and pyran moieties are essential for binding to the BMP-2 receptor active site.

Conclusions:

• Compound 4e emerged as a highly promising bone anabolic agent within the synthesized series.
• The benzofuran-pyran scaffold shows potential for developing new therapeutic leads for osteoporosis.
• Further exploration of compound 4e is warranted for its potential as a drug candidate for osteoporosis.